F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.“Every month that that drug is delayed means that I have to get chemo two more times,” said Dr. Ronald Silvestri, 77, a retired pulmonologist who has metastatic pancreatic cancer.